Abstract
Spinocerebellar Ataxia type 7 (SCA7) is a neurodegenerative disease characterized by progressive cerebellar ataxia and retinal degeneration. Increasing loss of visual function complicates the use of clinical scales to track the progression of motor symptoms, hampering our ability to develop accurate biomarkers of disease progression, and thus test the efficacy of potential treatments. In this cross-sectional study, we aimed to identify imaging measures of neurodegeneration, which may more accurately reflect SCA7 severity and progression. We analyzed diffusion tensor imaging (DTI) data collected from a cohort of 13 SCA7 patients and 14 healthy volunteers using two recent methodological advances: 1) a diffusion tensor-based image registration technique, and 2) a dual-compartment DTI model to control for the potential increase in extracellular CSF-like water due to neurodegeneration. These methodologies allowed us to assess both volumetric and microstructural abnormalities in both white and gray matter brain-wide in SCA7 patients for the first time. To measure tissue volume, we performed diffusion tensor-based morphometry (DTBM) using the tensor-based registration. To assess tissue microstructure, we computed the parenchymal mean diffusivity (pMD) and parenchymal fractional anisotropy (pFA) using the dual compartment model. This model also enabled us to estimate the parenchymal volume fraction (pVF), a measure of parenchymal tissue volume within a given voxel. While DTBM and pVF revealed tissue loss primarily in the brainstem, cerebellum, thalamus, and a subset of cerebral white matter tracts in patients, pMD and pFA detected microstructural abnormalities brain-wide (p < 0.05, FWE corrected; Hedge’s g > 1). This distinction was meaningful in terms of motor symptom severity, as we found that patient scores on the Scale for the Assessment and Rating of Ataxia correlated most strongly with cerebellar pVF (r = - 0.66, p = 0.015) and global white matter pFA (r = −0.64, p = 0.018). Since this contrast between focal tissue loss and global microstructural abnormality has previously been described in neuropathology, we believe the approach employed here is well suited for the in-vivo assessment of neurodegeneration. Moving forward, this approach could be applied to characterize the full spatiotemporal pattern of neurodegeneration in SCA7, and potentially develop an accurate imaging biomarker of disease progression.
Highlights
DTI study reveals brain-wide differences between SCA7 patients and controls.
DTI dual-compartment model controls for increased CSF-like free water in patients.
Tensor-based deformations show SCA7 tissue loss extends beyond cerebellum.
Focal atrophy, but global microstructural abnormalities were observed in SCA7.
Ataxia most correlated with cerebellar atrophy, global microstructural abnormality.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT02741440
Funding Statement
This work was supported by the Intramural Research Programs of NINDS and NEI, NIH, and R01 EY014061 to A.R.L.S.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
National Institutes of Health Institutional Review Board
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Abbreviations
- DTBM
- diffusion tensor-based morphometry
- DTI
- diffusion tensor imaging
- DWI
- diffusion weighted imaging
- FA
- fractional anisotropy
- GM
- gray matter
- HV
- healthy volunteer
- logJ
- natural log of the Jacobian determinant
- MD
- mean diffusivity
- MNI
- Montreal Neurological Institute
- MRI
- magnetic resonance imaging
- pFA
- parenchymal fractional anisotropy
- pMD
- parenchymal mean diffusivity
- pVF
- parenchymal volume fraction
- Qvoxels
- fraction of voxels
- SARA
- Scale for the Assessment and Rating of Ataxia
- SCA7
- Spinocerebellar Ataxia type 7
- TICV
- total intracranial volume
- VBM
- voxel-based morphometry
- WM
- white matter